Articles

Shares in GlaxoSmithKline fell in morning trade in London after it went hostile with its bid to acquire the American biotech Human Genome Sciences (NASDAQ:HGS). VIEW MORE[+]

Cytokinetics saw its shares jump almost 10 percent in pre market trading on Thursday, as it announced that it obtained fast track designation from the U.S. Food and Drug Administration for its drug ... VIEW MORE[+]

Drugmaker Vivus said Tuesday that U.S. regulators have delayed a decision on whether to approve its Qnexa obesity pill by three months to July. VIEW MORE[+]

Medical Facilities Corp. reported Thursday fourth-quarter revenue fell amid lower surgical and pain procedures as operating income declined. VIEW MORE[+]

Medical technology has been stalled in a quagmire of regulation, lowered usage and a more tight-fisted health insurance environment, but Analyst and Managing Director Joanne Wuensch of BMO Capital Mar... VIEW MORE[+]

Omeros saw its stock rise more than 22 percent Tuesday morning, following news that its OMS302 drug achieved both primary and secondary goals in a phase three study. VIEW MORE[+]

NanoViricides is a company that holds more than one promising clinical development programs under its belt, with its most advanced - FluCide - set to undergo FDA scrutiny in an upcoming pre-investiga... VIEW MORE[+]

Gilead Sciences said Friday the majority of hepatitis C patients in a trial experienced a viral relapse in their disease after being treated with an investigational drug labelled GS-7977, sending its ... VIEW MORE[+]

Human Genome Sciences has come up with a ‘poison pill’ defence against the US$2.6 billion hostile bid from Britain’s GlaxoSmithKline (LON:GSK). VIEW MORE[+]

Newly discovered biomarkers could provide physicians with information that will aid in the diagnosis and treatment of disease. VIEW MORE[+]

The Medipattern Corporation announced today that SonoCare, LLC ("SonoCare") has received Visualize:Vascular™ VIEW MORE[+]

With U.S. biomedical research under assault by everyone from patients to Congress for turning so few scientific discoveries into treatments VIEW MORE[+]

Allied Healthcare Group (ASX: AHZ) has increased its shareholding in Coridon after investing a further A$1 million. VIEW MORE[+]

Medical device companies need to demonstrate four qualities to be good investment ideas, according to Senior Medical Devices Analyst and Managing Director Jason Mills of Canaccord Genuity. VIEW MORE[+]

Developing vaccines to treat and/or prevent disease promises life-changing benefits for patients and unique opportunities for investors. VIEW MORE[+]

Advertisements Will Coincide with Attendance at the Heart Rhythm Society, World Congress of Cardiology and the American Telemedicine Association Conferences VIEW MORE[+]

Study reveals genetic variation among tumours VIEW MORE[+]

Medical supplies and diagnostics may not sound exciting, but recurring revenue is key to restful nights and steady growth. VIEW MORE[+]

After a three-and-one-half year slide, biotechnology stocks started 2012 with a powerful move to the upside. VIEW MORE[+]

The Supreme Court confronted the core of President Barack Obama's healthcare law on Tuesday, zeroing in on whether Congress had the power to require most people in the United States to buy medical ins... VIEW MORE[+]

The dart board will not help in picking medical technology stocks. VIEW MORE[+]

German chemicals and drugs group Bayer expects higher profit margins and sales at its healthcare division over the next three years, where product launches are set to boost prescription drug sales by ... VIEW MORE[+]

Researchers say their 3D point-of-care sensor, called oPad, can be printed on a simple office printer. VIEW MORE[+]

Discovery Laboratories Inc said U.S. health regulators have approved its drug to prevent a breathing disorder in premature infants, sending its shares up 35 percent in extended trade. VIEW MORE[+]

Developing and discovering myoblast and stem cell therapies resulting in regenerative treatment for heart damage repair VIEW MORE[+]

TORONTO, ONTARIO – CardioComm Solutions, Inc. (TSX VENTURE:EKG) today announced that an aggregate of 1,023,750 incentive stock options have been granted to Company employees. VIEW MORE[+]

Launch Coincides With Co-Sponsorship of USA Today's CardioVascular Health Supplement for National Heart Health Month TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) today announced t... VIEW MORE[+]

The Medipattern Corporation, a pioneer in the development of medical imaging software solutions that help medical practitioners to better understand lesions and critical anatomy VIEW MORE[+]

These cancer stem cells are difficult to kill because they don't divide rapidly--a common behavior that most cancer treatments target. VIEW MORE[+]

To reach his office in Galveston National Laboratory, where scientists study deadly pathogens such as the Ebola and Marburg viruses, director James Le Duc swipes his key card at the building's single ... VIEW MORE[+]